Tango Therapeutics Inc (TNGO)
6.44 unch (unch) 05/04/18 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,936 | 4,962 | 3,038 | -2,955 | -1,752 |
| Depreciation Amortization | 10,223 | 10,963 | 9,542 | 5,982 | 3,602 |
| Income taxes - deferred | 989 | 400 | 183 | 305 | 190 |
| Accounts receivable | -14,283 | -5,089 | -5,883 | -4,437 | -2,986 |
| Accounts payable and accrued liabilities | 1,595 | 32 | 1,310 | 3,054 | 172 |
| Other Working Capital | -13,400 | -7,752 | -5,382 | -733 | -1,659 |
| Other Operating Activity | 31,486 | 17,897 | 13,880 | 8,931 | 5,833 |
| Operating Cash Flow | $19,546 | $21,413 | $16,688 | $10,147 | $3,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,569 | -2,643 | -1,820 | -853 | -367 |
| Net Acquisitions | -881 | -20,845 | -38,410 | -22,194 | N/A |
| Investing Cash Flow | $-4,450 | $-23,488 | $-40,230 | $-23,047 | $-367 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 177 | 0 | 778 | 20,000 | 5,500 |
| Debt Repayment | -858 | -1,006 | -9,676 | -38,018 | -9,514 |
| Common Stock Issued | 2,100 | 4,861 | 41,903 | 68,582 | 300 |
| Common Stock Repurchased | -7,915 | -8,590 | -2,700 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 93 | -170 | 431 |
| Financing Cash Flow | $-6,496 | $-4,735 | $30,398 | $50,394 | $-3,283 |
| Exchange Rate Effect | -503 | -219 | -52 | 0 | 0 |
| Beginning Cash Position | 43,182 | 50,211 | 43,407 | 5,913 | 6,163 |
| End Cash Position | 51,279 | 43,182 | 50,211 | 43,407 | 5,913 |
| Net Cash Flow | $8,097 | $-7,029 | $6,804 | $37,494 | $-250 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,546 | 21,413 | 16,688 | 10,147 | 3,400 |
| Capital Expenditure | -3,569 | -2,643 | -1,820 | -853 | -367 |
| Free Cash Flow | 15,977 | 18,770 | 14,868 | 9,294 | 3,033 |